Strategy
Our group`s strategy is to perform basic and applied medicinal chemistry research at the leading national level and at a high international level, making our group a sought-after partner in multi-diciplinary projects with industry, international and national collaborators. Our research projects are within PET-technology, antibacterial agents, computational medicinal chemistry and resolution of inflammation processes.
The Medicinal Chemistry group's research related to the United Nations` Sustainable Development Goals.
Researchers in the Medicinal Chemistry Group contribute towards the following sustainability goals:
Our goal is to perform high-quality basic research and innovation that can contribute with new knowledge allowing for the treatment of various diseases that has a major impact on individuals and society. This is in line with SDG3: "ensure healthy lives and promote well-being for all at all ages". For example, our research on chronic, unresolved and excessive inflammation complies very well with SDG3.
In order to promote sustainable production and preparation of small molecular active pharmaceutical ingredients (APIs), new methodology is in high demand. One such area is organocatalysis, where we have made several contributions. Research activities performed in the groups of professors Jo Klaveness and Pål Rongved, have resultet in the establishment of three companies (Adjutec Pharma, DDL and Omegatri). This complies with SDG9 "build resilient infrastructure, promote inclusive and sustainable industrialization and foster innovation", and SDG12: "ensure sustainable consumption and production patterns".
Education and training
Our group aims at recruiting and train excellent candidates at MSc, PhD and postdoc levels who are attractive for industrial careers and academic positions. A list of graduated PhD and postdocs from 2012-2022 can be found here.
The Medicinal Chemistry group contribute in the following courses at the Department of pharmacy:
FARM1100 - Pharmaceutical Chemistry
FARM1130 - Pharmaceutically Based Organic Chemistry
FARM1150 - Pharmaceutically Based Biochemistry
FARM2100 - Medicinal Chemistry
FARM4130 - Applied Statistics for Pharmacists
FARM5000 - Preparation Course for Master in Pharmacy
FARM5110 - Industrial Pharmacy
FARM5190 - Synthesis of Bioactive Molecules
FARM4120K - Fra virkestoff til ferdig formulering
Collaboration
We collaborate with several academic groups in Norway and abroad, but also with pharmaceutical companies in Norway as well as abroad. For more information, please see the individual groups.
Life science
The Medicinal chemistry group and the Department of Pharmacy will move into the new Life Science building in 2026. Our groups research activities align exceptionally well with the 2019 Thematic Life Science Strategy at the faculty level where antimicrobial resistance, neuroscience, molecular and cellular mechanisms, drug development, digital life science, new health technologies are all listed in the strategy document (page 5). Moreover, our research and results have in small parts contributed towards the 2014 Life Science:UiO strategy. Our collaborations with groups in medicine, pharmacy, dentistry and biology/pharmacology, has enabled contribution towards the institutional strategies and objectives on collaborative health projects.
